4.6 Article

Local and systemic therapy may be safely de-escalated in elderly breast cancer patients in China: A retrospective cohort study

Related references

Note: Only part of the references are listed.
Article Oncology

Cancer statistics, 2022

Rebecca L. Siegel et al.

Summary: Each year, the American Cancer Society compiles data on cancer occurrence and outcomes in the United States. The latest data shows that breast and prostate cancer progress has stagnated, while lung cancer has shown improvements in survival rates. Lung cancer incidence for advanced disease has declined while localized-stage rates have increased, resulting in higher survival rates. Mortality patterns align with incidence trends, with lung cancer deaths declining rapidly, breast cancer deaths slowing, and prostate cancer deaths stabilizing.

CA-A CANCER JOURNAL FOR CLINICIANS (2022)

Article Oncology

Cancer treatment-related cardiac dysfunction in breast cancer survivors: A retrospective descriptive study using electronic health records from a Korean tertiary hospital

Arum Lim et al.

Summary: The overlap of breast cancer and cardiovascular diseases has increased due to early detection and treatment of breast cancer and aging population trends. This study found that breast cancer patients with pre-existing cardiovascular diseases have a high risk for cardiotoxicity, but baseline studies before chemotherapy are not sufficient to support the prevention and early detection of cardiotoxicity.

EUROPEAN JOURNAL OF ONCOLOGY NURSING (2022)

Review Oncology

Breast cancer in the oldest old (> 89 years): Tumor characteristics, treatment choices, clinical outcomes and literature review

Simona Di Lascio et al.

Summary: This study reviewed and analyzed the clinical characteristics, treatment, and outcomes of breast cancer patients aged 89 and older, highlighting the importance of sub-stratifying this heterogeneous group for tailored treatment. Most patients did not receive adjuvant treatment, and a small percentage experienced relapse.
Article Oncology

Bridging the age gap in breast cancer. Impacts of omission of breast cancer surgery in older women with oestrogen receptor positive early breast cancer. A risk stratified analysis of survival outcomes and quality of life

Lynda Wyld et al.

Summary: A propensity-matched study was conducted on breast cancer patients aged ≥ 70, showing that surgery is oncologically superior to primary endocrine therapy (PET) in most older women with early ER+ breast cancer. However, in some less fit, older patients, PET may be a safe treatment option.

EUROPEAN JOURNAL OF CANCER (2021)

Review Oncology

Clinical Perspectives in Addressing Unsolved Issues in (Neo)Adjuvant Therapy for Primary Breast Cancer

Ryungsa Kim et al.

Summary: The development of adjuvant and neoadjuvant therapies, along with breast cancer surgery, has significantly improved survival rates of breast cancer patients over the past 50 years. However, distant metastasis recurrence remains a challenge, despite advancements in treatment. Further research in antitumor immunity, drug resistance, and targeted therapy based on genomic analysis is needed to achieve complete cure for primary breast cancer.

CANCERS (2021)

Article Oncology

Bridging The Age Gap: observational cohort study of effects of chemotherapy and trastuzumab on recurrence, survival and quality of life in older women with early breast cancer

Alistair Ring et al.

Summary: Chemotherapy reduced the risk of metastatic recurrence in high-risk early breast cancer patients, with survival benefits seen only in those with ER-negative cancer. However, there were significant but transient negative impacts on quality of life for patients undergoing chemotherapy.

BRITISH JOURNAL OF CANCER (2021)

Review Oncology

Updated recommendations regarding the management of older patients with breast cancer: a joint paper from the European Society of Breast Cancer Specialists (EUSOMA) and the International Society of Geriatric Oncology (SIOG)

Laura Biganzoli et al.

Summary: Breast cancer in older adults is becoming more common and challenging to manage due to its heterogeneity and lack of specific evidence. An expert taskforce expanded and updated guidelines with endorsement from the European Cancer Organisation, including factors like chemotherapy toxicity prediction, cultural and social considerations, and genetic screening. Age should not be the sole factor in decision-making, with careful consideration of geriatric assessments, life expectancy, and patient preferences.

LANCET ONCOLOGY (2021)

Article Medicine, General & Internal

Outcomes After Sentinel Lymph Node Biopsy and Radiotherapy in Older Women With Early-Stage, Estrogen Receptor-Positive Breast Cancer

Neil Carleton et al.

Summary: This study found that receiving SLNB or RT did not improve LRFS or DFS in older patients with ER-positive, clinically node-negative breast cancer. The study supports the continued deimplementation of both SLNB and RT in accordance with the Choosing Wisely and National Comprehensive Cancer Network guidelines.

JAMA NETWORK OPEN (2021)

Article Oncology

Population-based analysis of non-operative management and treatment patterns in older women with estrogen receptor-positive breast cancer

David Tejera et al.

Summary: The majority of older women with ER + HER2- breast cancer tend to undergo primary breast surgery as the dominant management strategy, but omission of axillary staging and adjuvant radiation is seen in a minority of eligible women undergoing breast conservation for early-stage disease, with a more pronounced trend as age increases.

BREAST CANCER RESEARCH AND TREATMENT (2021)

Review Oncology

De-escalating adjuvant therapies in older patients with lower risk estrogen receptor-positive breast cancer treated with breast-conserving surgery: A systematic review and meta-analysis

Marie-France Savard et al.

Summary: A systematic review found that radiation therapy can be omitted in older patients with lower-risk breast cancer after BCS, but more trials on the omission of endocrine therapy are needed.

CANCER TREATMENT REVIEWS (2021)

Article Oncology

Impact of Rehabilitation on Breast Cancer Related Fatigue: A Pilot Study

Marco Invernizzi et al.

FRONTIERS IN ONCOLOGY (2020)

Article Medicine, Research & Experimental

Side effects of adjuvant chemotherapy and their impact on outcome in elderly breast cancer patients: a cohort study

Valentina Zanuso et al.

FUTURE SCIENCE OA (2020)

Article Oncology

Treatment of elderly breast cancer patients in a breast center in India

Asha Reddy et al.

INDIAN JOURNAL OF CANCER (2019)

Article Surgery

Breast Cancer in the Elderly

Flora Varghese et al.

SURGICAL CLINICS OF NORTH AMERICA (2018)

Article Oncology

Clinical characteristics and outcomes of older women with breast cancer in Mexico

Paula Cabrera-Galeana et al.

JOURNAL OF GERIATRIC ONCOLOGY (2018)

Article Chemistry, Medicinal

Adjuvant Treatment of Early Breast Cancer in the Elderly

Giovanni M. Fadda et al.

MEDICINAL CHEMISTRY (2016)

Review Oncology

Age-related Disparity: Breast Cancer in the Elderly

Rahul Gosain et al.

CURRENT ONCOLOGY REPORTS (2016)

Article Medicine, General & Internal

Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer

Sarah C. Darby et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

Article Oncology

Improvement in Breast Cancer Outcomes Over Time: Are Older Women Missing Out?

Benjamin D. Smith et al.

JOURNAL OF CLINICAL ONCOLOGY (2011)

Article Oncology

Breast Cancer Among the Oldest Old: Tumor Characteristics, Treatment Choices, and Survival

Mara A. Schonberg et al.

JOURNAL OF CLINICAL ONCOLOGY (2010)

Article Oncology

Pulmonary changes after radiotherapy for conservative treatment of breast cancer: A prospective study

Marco Krengli et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)

Article Medicine, General & Internal

Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer

KS Hughes et al.

NEW ENGLAND JOURNAL OF MEDICINE (2004)